mid-cheek benign tumors
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All patients were evaluated by ultrasound, computed tomography (CT), or magnetic resonance imaging (MRI) with a mass located in the mid-cheek region with a long-axis length =4 cm; the pathological diagnosis was benign tumor by aspiration biopsy. Patients aged 10~65 years old who could tolerate surgery under general anesthesia and had no contraindications to surgery were required. No history of radiotherapy or facial paralysis. All patients signed an informed consent form for this randomized study. Minors’ informed consent was obtained from their legal guardians for study participation. The informed consent to publish identifying information and images was obtained from patients.
Exclusion criteria
Exclusion criteria: Patients with too large tumors (long-axis length >4 cm), suspicious malignant tumors, acute inflammation, recurrent tumors, and those who could not complete or be lost to follow-up were excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| satisfaction with the aesthetic outcome;postoperative drainage amount and time;perioperative complications;incision length;estimated intraoperative blood loss;the conversion rate between open surgery and endoscopic-assisted surgery;tumor recurrence rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| pathological results;maximum long-axis diameter of the tumor;operative time;follow-up time; | — |
Countries
China
Contacts
Department of Oral and Maxillofacial Surgery, Qilu Hospital of Shandong University, Jinan, China